Caricamento...

Immunotherapy in pancreatic adenocarcinoma—overcoming barriers to response

Pancreatic adenocarcinoma (PAC) remains one of the leading causes of cancer-related death. Despite multiple advances in targeted and immune therapies, the 5-year survival in advanced PAC remains poor. In this review, we discuss some of the unique aspects of the tumor microenvironment (TME) in PAC th...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Gastrointest Oncol
Autori principali: Rosenberg, Ari, Mahalingam, Devalingam
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2018
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5848027/
https://ncbi.nlm.nih.gov/pubmed/29564181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2018.01.13
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !